[Cytogenetic studies in the course  of antiblastic therapy].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002822:Choriocarcinoma / Q000188:drug therapy*; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011247:Pregnancy
D000970:Antineoplastic Agents
Quadri citogenetici in corso di terapia antiblastica.